Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Faria Limited LLC dba Sheffield Pharmaceuticals

Faria Limited LLC dba Sheffield Pharmaceuticals Recalls

All product recalls associated with Faria Limited LLC dba Sheffield Pharmaceuticals.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

304

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 4061–4080 of 4747 recalls

Triple Antibiotic Ointment (Sheffield Pharmaceuticals) – Stability Failure (2013)

Failed Stability Specifications: Unable to meet shelf life expiry.

Class IIILow

FDAMay 28, 2013CA, GA, PA +1 more• Faria Limited LLC dba Sheffield Pharmaceuticals

Actiq Fentanyl 200mcg (Teva Pharmaceuticals) – Failed Dissolution Test (2013)

Failed Dissolution Specification; during stability testing

Class IIModerate

FDAMay 28, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Nimodipine Capsules (Sun Pharma) – crystallization risk (2013)

Crystallization; crystallized nimodipine

Class II

1...202 203204205 206...238

Page 204 of 238Next

Moderate

FDAMay 21, 2013Nationwide• Sun Pharmaceutical Industries Inc.

Belladonna Alkaloids Tablets (West-Ward) – foreign substance (2013)

Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.

Class IIModerate

FDAMay 16, 2013Nationwide• West-Ward Pharmaceutical Corp.

Belladonna Alkaloids Tablets (West-Ward) – cross contamination (2013)

Cross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets contained a trace amount of Methocarbamol.

Class IIModerate

FDAMay 16, 2013Nationwide• West-Ward Pharmaceutical Corp.

Ranitidine Syrup (Actavis) – Impurity Specification Failure (2013)

Failed Impurity/Degradation Specification; "Related Compound C"

Class IIModerate

FDAMay 15, 2013Nationwide• Actavis South Atlantic LLC

Nicardipine Hydrochloride Injection (West-ward) – Impurity Specification (2013)

Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D)

Class IIILow

FDAMay 13, 2013Nationwide• West-ward Pharmaceutical Corp.

Warfarin Sodium Tablets (Zydus) – Tablet Specification Issue (2013)

Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.

Class IHigh

FDAMay 13, 2013Nationwide• Zydus Pharmaceuticals USA Inc

Dicopanol FusePaq Kit (Fusion) – Microbial Contamination (2013)

Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.

Class IIModerate

FDAMay 8, 2013CA• Fusion Pharmaceuticals, LLC

Derma-Smoothe/FS Topical Oil (Hill) – Subpotent Drug (2013)

Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Class IIILow

FDAMay 7, 2013Nationwide• Hill Dermaceuticals, Inc.

CLENZIderm (Medicis) – mislabeled product (2013)

cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy

Class IIModerate

FDAMay 1, 2013Nationwide• Medicis Pharmaceutical Corp

XYMOGEN EP Dietary Supplement (XYMOGEN) – Undeclared Allergens (2013)

Undeclared Soy

Undeclared Soy and Milk on the label.

Class IHigh

FDAMay 1, 2013AL, AK, AZ +39 more• Atlantic Pro Nutrients, Inc. dba XYMOGEN

Amoxicillin Oral Suspension (Teva) – Powder Discoloration (2013)

Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner foil seal of the bottles.

Class IIILow

FDAApr 26, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

DOMETIC 9100 POWER AWNING Equipment Recall: EQUIPMENT

Dometic is recalling certain WeatherPro motor powered awning models 805, 815, 825, 835, 845, 885, 855, and 905: 9100 Power awning models 910, 912, 913, 914, 915, 916, 917, and 91; and certain awning motor service kits with part numbers starting with 3307923 and 3310423. The serial number range for the WeatherPro and 9100 motor powered awnings is 306XXXXX thru 314XXXXX. These motor powered awnings were either sold in the aftermarket as replacement equipment or installed as original equipment on various recreation vehicles and horse trailers. The awning motor service kits were sold in the aftermarket as service parts for product already installed on recreation vehicles or horse trailers and do not carry an individual serial number. The awning motor service kit must be located by the part number shown above. The motor powered awnings and awning motor service kits were manufactured between February 13, 2013 and April 9, 2013. If the awning or service part installation sequence is not completely followed, the awning motor may unknowingly become damaged.

NHTSAApr 22, 2013Nationwide• DOMETIC

Ropinirole Tablets (Mylan) – Incorrect Labeling (2013)

Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..

Class IIModerate

FDAApr 22, 2013Nationwide• Mylan Pharmaceuticals Inc.

Amlodipine Besylate Tablets (Walmart) – Label Strength Error (2013)

Labeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description. Tablet strength is 10 mg.

Class IIModerate

FDAApr 22, 2013Nationwide• Legacy Pharmaceutical Packaging LLC

Glimepiride Tablets (Qualitest) – Oversized Tablet (2013)

Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.

Class IIModerate

FDAApr 19, 2013Nationwide• Qualitest Pharmaceuticals

NORepinephrine IV Sodium Chloride (Unique Pharmaceutical) – mold contamination (2013)

Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.

Class IIModerate

FDAApr 17, 2013PA, TN, TX• Unique Pharmaceutical, Ltd

Winn Dixie Organic Apple Juice (Winn-Dixie) – patulin excess (2013)

The product is being recalled as a precaution because it could have levels of "patulin" that exceeds FDA limits.

Class IIModerate

FDAApr 11, 2013AL, FL, GA +2 more• Winn-Dixie Logistics, Inc.

Perfect 3000 Chocolate Powder (Kabco Pharmaceuticals) – Consent Decree Violation (2013)

Firm had distributed the bulk product in violation of the Consent Decree for Permanent Injunction (12-CV-3468).

Class IIModerate

FDAApr 9, 2013NY• Kabco Pharmaceuticals, Inc.